Sherman Darren
Known title: See RemarksCIK: 0001723524
Sherman Darren's purchase track record
Sherman Darren has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/26/2026 | OBIO | $11K | pending | pending | — |
| 8/25/2025 | OBIO | $8K | +86.2% | +55.0% | +6.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OBIO | ▼ Sell | Open Market | 15,000 | $95K | 10/1/2026 | View on chart |
| OBIO | ▼ Sell | Open Market | 15,000 | $74K | 9/1/2026 | View on chart |
| OBIO | ▲ Buy | Open Market | 2,000 | $11K | 8/26/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 4,925 | $26K | 8/26/2026 | View on chart |
| OBIO | ▼ Sell | Open Market | 15,000 | $61K | 8/3/2026 | View on chart |
| OBIO | ▼ Sell | Open Market | 15,000 | $64K | 7/1/2026 | View on chart |
| OBIO | ▼ Sell | Open Market | 15,000 | $58K | 6/1/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 4,925 | $20K | 5/28/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 33,317 | $152K | 3/25/2026 | View on chart |
| OBIO | ▲ Buy | Grant | 397,000 | $0 | 2/12/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 5,588 | $24K | 1/2/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 40,340 | $216K | 11/25/2025 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 40,340 | $110K | 9/3/2025 | View on chart |
| OBIO | ▲ Buy | Open Market | 3,000 | $8K | 8/25/2025 | View on chart |
| OBIO | ▲ Buy | Grant | 120,000 | $0 | 8/7/2025 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 45,843 | $135K | 5/28/2025 | View on chart |
| OBIO | ▲ Buy | Grant | 115,708 | $0 | 4/4/2025 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 31,815 | $177K | 12/5/2024 | View on chart |
| OBIO | ▼ Sell | Open Market | 6,904 | $37K | 9/10/2024 | View on chart |
| OBIO | ▼ Sell | Open Market | 6,804 | $37K | 9/9/2024 | View on chart |
| OBIO | ▼ Sell | Open Market | 6,819 | $39K | 9/6/2024 | View on chart |
| OBIO | ▼ Sell | Open Market | 6,961 | $41K | 9/5/2024 | View on chart |
| OBIO | ▼ Sell | Open Market | 6,837 | $42K | 9/4/2024 | View on chart |
| OBIO | ▲ Buy | Grant | 176,667 | $0 | 5/8/2024 | View on chart |
| OBIO | ▲ Buy | Grant | 539,667 | $0 | 7/20/2023 | View on chart |
| OBIO | ▲ Buy | Option Exercise | 14,959 | — | 4/12/2023 | View on chart |
| OBIO | ▲ Buy | Grant | 68,189 | — | 1/26/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
OBIO Shares Rise 5.2% Amid Positive Momentum
Orchestra BioMed Holdings (OBIO) shares recently increased by 5.2%, a move that some observers see as a sign of strengthening momentum. The stock currently trades within its 52-week range of $2.20 to $6.48. Analysts maintain an average price target of $12.14, suggesting a significant gap between the current market price and professional estimates.
OBIO Shares Rise 5.2% Amid Positive Momentum. Orchestra BioMed Holdings (OBIO) shares recently increased by 5.2%, a move that some observers see as a sign of strengthening momentum. The stock currently trades within its 52-week range of $2.20 to $6.48. Analysts maintain an average price target of $12.14, suggesting a significant gap between the current market price and professional estimates.